January 18, 2019
Astellas Pharma and the Japan arm of AstraZeneca (AZ) said on January 17 that they will discontinue their sales and promotion collaboration for the asthma and COPD treatment Symbicort (budesonide + formoterol) on July 30. They did not reveal the...read more